A protein on the surface of some tiny particles in human blood may help researchers pick out material released by neurons, the brain’s nerve cells. The discovery, by teams at the Wyss Institute for Biologically Inspired Engineering, the Massachusetts Institute of Technology and other institutions, points toward a way to study brain cells without sampling them directly.
Neurons are difficult to reach, but they release clues into the fluids around them. Cells shed membrane-wrapped packets called extracellular vesicles, or EVs, which can carry RNA and proteins from their cell of origin. EVs circulate in blood and also appear in cerebrospinal fluid, the liquid around the brain and spinal cord. The challenge has been telling which cells released which particles.
In a paper published in Nature Neuroscience, the researchers describe a way to identify and isolate EVs bearing a protein strongly associated with neurons. Their goal is to examine the RNA or protein cargo inside those particles, which could offer a molecular picture of what is happening in the brain over time. First author Dmitry Ter-Ovanesyan said the team hoped to use a fluid that can be sampled, ideally blood, to make the brain more accessible to study.
The team built a framework for choosing candidate markers. A useful protein had to cross the EV’s outer membrane, be made mainly by neurons, and be detectable on the surface of some EVs in cerebrospinal fluid, blood plasma or both. A surface protein matters because an antibody that recognizes it can act like a handle, pulling the vesicle along for isolation.
To assess whether proteins were neuron-linked, the researchers combined several kinds of evidence. They examined bulk RNA sequencing, which measures gene activity across groups of cells, and used Tau scores to estimate whether a gene is especially active in one tissue or cell type. They also analyzed single-cell RNA sequencing data with SCimilarity, a tool developed by Graham Heimberg in Aviv Regev’s group, to compare gene activity patterns in individual cells.
Then they needed to check which proteins were actually present on EVs. That meant tackling a problem with blood plasma: it contains abundant free proteins such as albumin, which can overwhelm the much weaker EV protein signal. The researchers developed a purification approach called multi-mode resin, or MMR, slurry. Porous beads trap smaller free proteins such as albumin while leaving the vesicles in the sample, allowing the team to study EV proteins with mass spectrometry, a method that measures proteins.
The work establishes a strategy for finding and separating neuron-associated vesicles, rather than a ready-made test that can read brain activity in a clinic. Further research will be needed to establish what the particles’ cargo can reliably reveal and how useful the approach may be in practice. Still, the method offers a route to follow molecular clues from hard-to-reach brain cells through a sample of blood or cerebrospinal fluid—one small step toward studying the brain with less invasive tools.
